Astria Therapeutics Inc (ATXS) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Astria Therapeutics Inc   (NASDAQ: ATXS)


Astria Therapeutics Inc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Astria Therapeutics Inc's ROI in the third quarter of 2025?
Astria Therapeutics Inc recorded a cumulative net loss of $-124 million during 12 months ending in the third quarter of 2025, resulting in a negative return on investment (ROI) of -43.97%.

Within the Healthcare sector 481 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from 3739 to 3782.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Investment Change TTM -13.75 % 6.89 % 31.93 % 65.37 % 59.94 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 248 264 293 323 346
Return On Investment (TTM) -43.97 % -38.15 % -32.9 % -27.15 % -30.59 %
ATXS's Overall Ranking # 3782 # 3739 # 3712 # 4162 # 3726
Seq. Investment Change TTM -7.96 % -6.68 % -5.39 % 6.12 % 14.08 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -124 -117 -108 -94 -100

ATXS Company Profile >> Back to ATXS Roi Comparisons >> See Annual ATXS Return On Investment



Return On Investment ATXS's Ranking
Within: No.
Industry # 198
Sector # 482
Overall # 3782

Return On Investment Statistics
High Average Low
-26.25 %
-81.17 %
-278.1 %
(Jun 30 2023)   (Mar 31 2021)







Financial Statements
Astria Therapeutics Inc's III. Quarter Investments $ 248 Millions ATXS's Balance sheet
Astria Therapeutics Inc's III. Quarter Income $ -32 Millions Quarterly ATXS's Income Statement
ATXS's Income by Division See ATXS's Income by Division


ATXS Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 323 243 222 122 41
Y / Y Investment Growth 32.95 % 9.72 % 81.16 % 197.84 % 11.75 %
Net Income in Millions -94 -73 -52 -219 -37
Y / Y Net Income Growth - - - - -
Annual Return On Investment -29.16 % -29.98 % -23.39 % -179.34 % -90.83 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ATXS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ATXS's Competitors
Subscribers only: Roi for Astria Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ATXS's Customers

Other Ratios
ATXS's Roa ATXS's Inventory Turnover Ratio ATXS's Growth Rates ATXS's Dividend Statistics
ATXS's Profitability Ratios ATXS's Asset Turnover Ratio ATXS's Dividend Growth
ATXS's Roe ATXS's Valuation Ratios ATXS's Financial Strength Ratios ATXS's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-26T07:21:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.